wragg VKTX's Investment Thesis Is Promising, Made Possible By The GLP-1 Hype We previously covered Novo Nordisk (NVO) and Eli Lilly and Company (LLY) discussing their prospects and pipelines attributed to the market exuberance surrounding GLP-1 therapies. For this particular article, we will be looking at Viking Therapeutics, Inc. (NASDAQ:NASDAQ:VKTX) and sharing our findings about the stock, continuing the theme surrounding obesity therapies. VKTX Pipeline VKTXFor the uninitiated, VKTX is a pre-revenue ...